This Article Full Text Full Text (PDF) All Versions of this Article: 108/4/407    most recent 01.CIR.0000084502.02147.83v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chang, J. Articles by Schwartz, R. J. Search for Related Content PubMed PubMed Citation Articles by Chang, J. Articles by Schwartz, R. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM Protein UniGene Substance via MeSH Medline Plus Health Information Heart Failure Related Collections Apoptosis

(Circulation. 2003;108:407.)
© 2003 American Heart Association, Inc.

Clinical Investigation and Reports

Inhibitory Cardiac Transcription Factor, SRF-N, Is Generated by Caspase 3 Cleavage in Human Heart Failure and Attenuated by Ventricular Unloading

Jiang Chang, MD, PhD; Lei Wei, PhD; Takayuki Otani, MS; Keith A. Youker, PhD; Mark L. Entman, MD; Robert J. Schwartz, PhD

From the Departments of Molecular and Cellular Biology and Medicine, Division of Cardiovascular Sciences, Center for Cardiovascular Development, DeBakey Heart Center, Methodist Hospital, Baylor College of Medicine, Houston, Tex.

Correspondence to Dr Robert J. Schwartz, Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. E-mail schwartz{at}bcm.tmc.edu

Received January 27, 2003; de novo received May 30, 2003; revision received June 12, 2003; accepted June 16, 2003.

Background— Knowledge about molecular mechanisms leading to heart failure is still limited, but reduced gene activities and modest activation of caspase 3 are hallmarks of end-stage heart failure. We postulated that serum response factor (SRF), a central cardiac transcription factor, might be a cleavage target for modest activated caspase 3, and this cleavage of SRF may play a dominant inhibitory role in propelling hearts toward failure.

Methods and Results— We examined SRF protein levels from cardiac samples taken at the time of transplantation in 13 patients with end-stage heart failure and 7 normal hearts. Full-length SRF was markedly reduced and processed into 55- and 32-kDa subfragments in all failing hearts. SRF was intact in normal samples. In contrast, the hearts of 10 patients with left ventricular assist devices showed minimal SRF fragmentation. Specific antibodies to N- and C-terminal SRF sequences and site-directed mutagenesis revealed 2 alternative caspase 3 cleavage sites, so that 2 fragments were detected of each containing either the N- or C-terminal SRF. Expression of SRF-N, the 32-kDa fragment, in myogenic cells inhibited the transcriptional activity of -actin gene promoters by 50% to 60%, which suggests that truncated SRF functioned as a dominant-negative transcription factor.

Conclusions— Caspase 3 activation in heart failure sequentially cleaved SRF and generated a dominant-negative transcription factor, which may explain the depression of cardiac-specific genes. Moreover, caspase 3 activation may be reversible in the failing heart with ventricular unloading.

Key Words: heart failure • serum response factor • apoptosis • heart-assist device

This article has been cited by other articles:

				J. Huang, M. Min Lu, L. Cheng, L.-J. Yuan, X. Zhu, A. L. Stout, M. Chen, J. Li, and M. S. Parmacek Myocardin is required for cardiomyocyte survival and maintenance of heart function PNAS, November 3, 2009; 106(44): 18734 - 18739. [Abstract] [Full Text] [PDF]

				G. Gary-Bobo, A. Parlakian, B. Escoubet, C. A. Franco, S. Clement, P. Bruneval, D. Tuil, D. Daegelen, D. Paulin, Z. Li, et al. Mosaic inactivation of the serum response factor gene in the myocardium induces focal lesions and heart failure Eur J Heart Fail, July 1, 2008; 10(7): 635 - 645. [Abstract] [Full Text] [PDF]

				J. Chang, M. Xie, V. R. Shah, M. D. Schneider, M. L. Entman, L. Wei, and R. J. Schwartz Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis PNAS, September 26, 2006; 103(39): 14495 - 14500. [Abstract] [Full Text] [PDF]

				G.C. T. Pipes, E. E. Creemers, and E. N. Olson The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes & Dev., June 15, 2006; 20(12): 1545 - 1556. [Abstract] [Full Text] [PDF]

				D. B. Sawyer Heart Failure Research Continues to Reveal the Flaws in Nature's Unintelligent Design Circulation, November 8, 2005; 112(19): 2891 - 2893. [Full Text] [PDF]

				A. Parlakian, C. Charvet, B. Escoubet, M. Mericskay, J. D. Molkentin, G. Gary-Bobo, L. J. De Windt, M.-A. Ludosky, D. Paulin, D. Daegelen, et al. Temporally Controlled Onset of Dilated Cardiomyopathy Through Disruption of the SRF Gene in Adult Heart Circulation, November 8, 2005; 112(19): 2930 - 2939. [Abstract] [Full Text] [PDF]

				Z. Niu, W. Yu, S. X. Zhang, M. Barron, N. S. Belaguli, M. D. Schneider, M. Parmacek, A. Nordheim, and R. J. Schwartz Conditional Mutagenesis of the Murine Serum Response Factor Gene Blocks Cardiogenesis and the Transcription of Downstream Gene Targets J. Biol. Chem., September 16, 2005; 280(37): 32531 - 32538. [Abstract] [Full Text] [PDF]

				S. X. Zhang, E. Garcia-Gras, D. R. Wycuff, S. J. Marriot, N. Kadeer, W. Yu, E. N. Olson, D. J. Garry, M. S. Parmacek, and R. J. Schwartz Identification of Direct Serum-response Factor Gene Targets during Me2SO-induced P19 Cardiac Cell Differentiation J. Biol. Chem., May 13, 2005; 280(19): 19115 - 19126. [Abstract] [Full Text] [PDF]